Telemedicine and Depression Screening After the Start of the COVID-19 Pandemic

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2024 Feb 12

PMID 38345822

Authors

Maria E Garcia

John Neuhaus

Jennifer Livaudais-Toman

Mitchell D Feldman

Lisa Ochoa-Frongia

Elaine Khoong

Leah S Karliner

Affiliations

Soon will be listed here.

Citing Articles

Global trends in depressive disorder prevalence and DALYs among young populations: a comprehensive analysis from 1990 to 2021.

Yang E, Chen F, Yang Y, Zhang Y, Lin H, Zhang Y BMC Psychiatry. 2024; 24(1):943.

PMID: 39716116 PMC: 11667871. DOI: 10.1186/s12888-024-06419-2.

Depression Treatment After a Positive Depression Screen Result.

Garcia M, Ochoa-Frongia L, Neuhaus J, Hong J, Hinton L, Livaudais-Toman J JAMA Intern Med. 2024; 185(2):221-229.

PMID: 39652335 PMC: 11791713. DOI: 10.1001/jamainternmed.2024.6211.

References

Ettman C, Cohen G, Abdalla S, Sampson L, Trinquart L, Castrucci B . Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults. Lancet Reg Health Am. 2021; 5:100091. PMC: 8488314. DOI: 10.1016/j.lana.2021.100091. View

Garcia M, Hinton L, Neuhaus J, Feldman M, Livaudais-Toman J, Karliner L . Equitability of Depression Screening After Implementation of General Adult Screening in Primary Care. JAMA Netw Open. 2022; 5(8):e2227658. PMC: 9389351. DOI: 10.1001/jamanetworkopen.2022.27658. View

Collier Villaume S, Chen S, Adam E . Age Disparities in Prevalence of Anxiety and Depression Among US Adults During the COVID-19 Pandemic. JAMA Netw Open. 2023; 6(11):e2345073. PMC: 10690464. DOI: 10.1001/jamanetworkopen.2023.45073. View